Clinical Trial Update: Aspirin and Plavix Following Coronary Artery Bypass Grafting [Phase 4]

View source ↗

Summary

Phase 4 trial update examining aspirin plus clopidogrel after coronary artery bypass grafting; the study was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Aspirin (Aspirin)
• Plavix (clopidogrel)

Snippet

Sponsor: Ahmad Slim | Conditions: Coronary Graft Patency | Phase 4 | Status: TERMINATED | Results posted: 2015-05-19